ArticleAMB Express2025
Synthesis of Silver/Zinc@Lignin nanoparticles using peanut shells: photocatalytic and biological activity.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In this paper, zinc and silver-doped lignin nanoparticles (Ag/Zn@Lignin nanoparticles) were synthesized in two steps using peanut outer shells. The optical properties of NPs were analyzed through UV-Vis and PL measurements, while X-ray analysis approved their crystal structure. The surface characteristics and chemical composition of NPs were identified using FTIR analysis. TEM images of Ag/Zn@Lignin nanoparticles showed spherical morphology with an average size of about 22.71 nm. The antibacterial activity of Ag/Zn@Lignin nanoparticles was assessed against gram-negative and gram-positive bacteria, and the results exhibited strong antibacterial properties against the pathogenic strain compared to the standard. The MTT test results indicated that Ag/Zn@Lignin nanoparticles were more sensitive against cancer cells (Huh-7) in comparison with normal cells (L929), and IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.